Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 30;6(7):2092–2106. doi: 10.1182/bloodadvances.2021004571

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

PMC Copyright notice

Figure 6. — Srsf2^P95H/+ cells are sensitive to the CDK6 inhibitor palbociclib and the spliceosome inhibitor Pladienolide B. (A) The guide count for CDK6 sgRNA in Srsf2^+/+ and Srsf2^P95H/+ cells over the course of the screen. (B) The cell-cycle stage distribution of Srsf2^P95H/+ and Srsf2^+/+ cells at day 18 after tamoxifen cessation. No statistical difference detected between P95H and WT cells. (C) Hoxb8 GM-CSF Srsf2^P95H/+ cell lines and sorted primary Srsf2^P95H/+ LKS⁺ cells are sensitive to palbociclib and Pladienolide B after 4 days of drug culture. Hoxb8 GM-CSF cell lines: n = 3 per genotype for roscovitine and Pladienolide B, n = 2 for palbociclib. Extra sum-of-squares F test. LKS⁺ cells, n = 1 per genotype. LKS⁺, lin⁻ckit⁺Sca-1⁺.

Figure 6. — Srsf2^P95H/+ cells are sensitive to the CDK6 inhibitor palbociclib and the spliceosome inhibitor Pladienolide B. (A) The guide count for CDK6 sgRNA in Srsf2^+/+ and Srsf2^P95H/+ cells over the course of the screen. (B) The cell-cycle stage distribution of Srsf2^P95H/+ and Srsf2^+/+ cells at day 18 after tamoxifen cessation. No statistical difference detected between P95H and WT cells. (C) Hoxb8 GM-CSF Srsf2^P95H/+ cell lines and sorted primary Srsf2^P95H/+ LKS⁺ cells are sensitive to palbociclib and Pladienolide B after 4 days of drug culture. Hoxb8 GM-CSF cell lines: n = 3 per genotype for roscovitine and Pladienolide B, n = 2 for palbociclib. Extra sum-of-squares F test. LKS⁺ cells, n = 1 per genotype. LKS⁺, lin⁻ckit⁺Sca-1⁺.